Scopio Labs, a Parsippany, NJ-based developer of Full-Area Cell Morphology imaging and evaluation platform, raised $10M in Sequence D extension funding.
The spherical was led by Viola Progress, bringing the full to $52M.
The corporate intends to make use of the funds to increase operations and its improvement efforts.
Led by CEO Itai Hayut, Scopio Labs improves the cell morphology evaluation, providing a set of digital imaging and evaluation platforms that assist lab scientists and clinicians with early detection and prognosis of blood-related medical circumstances, expediting sufferers’ entry to life-saving remedies. Its high-resolution imaging and embedded AI mix for extra environment friendly distant workflow by the safe hospital community, contributing to raised diagnostics throughout the continuum of care.
FinSMEs
25/07/2025
